When Should You SELL Your Stocks (8 Reasons to Sell Your Stocks) Click to watch on Youtube.

Prometheus Biosciences Inc Stock Forecast

NASDAQ:RXDX BUY

$48.06 (-1.37%)

Volume: 499.125k

Closed: Aug 16, 2022

Hollow Logo Score: 1.169

Prometheus Biosciences Inc Stock Forecast

BUY NASDAQ:RXDX
$48.06 (-1.37%)

Volume: 499.125k

Closed: Aug 16, 2022

Score Hollow Logo 1.169

RXDX Price Targets and Analyst Ratings NASDAQ:RXDX

RXDX Forecast. What You Should Know.

RXDX Historical Ratings and Targets

FAQ

What are analyst ratings?
Analyst ratings are recommendations made by various stock analysts. Public companies are rated by analysts who monitor their industries. These stock ratings result from a thorough evaluation of a traded company using known metrics such as sales, earnings, and potential catalysts. Read More...

What to keep in mind using analyst ratings?
The best way to use analyst ratings is to supplement your investment research. Please do not rely on them blindly; instead, use them as one tool in your decision-making process. Also, be sure to pay attention to the date of the rating. Analyst ratings can change quickly, and a rating that was accurate six months ago might not be relevant today. Read More...

What is a price target in trading?
A price target is a stock market term used by investors and analysts to indicate the level at which they believe a stock will trade. The price target is based on several factors, including a company's earnings, revenue, and valuation. Determining a price target can be tricky, as it is an estimate and not always accurate. However, it can guide investors looking to buy or sell a stock. Read More...

Unlock All Premium Features! Go Premium! Only $19.90/Month

Unlock the Top 5 candidates in every list
Unlock full Ultimate List Builder
Golden Star lists & Auto Portfolios
Possible Runners & Moving Average lists
Ad-free browsing
Save data in PDF

About Prometheus Biosciences Inc

Prometheus Biosciences Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial for the treatment of ulcerative colitis and Crohn's disease, as well as systemic sclerosis-associated ... Read more

.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT